Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pecilocin
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Pecilocin is an antimycotic antibiotic that has been used for the treatment of fungal infections, particularly those affecting the skin and nails. It exhibits antifungal activity against various yeasts and dermatophytes. Historically, it has been compared to other antifungal agents such as miconazole, nystatin, and natamycin. Allergic reactions to Pecilocin have been reported in some patients.
- Brand names
- Variotin
- Other names
- pecilocinum
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))HTR2A (Serotonin receptor 5-HT2A)HTR2B (5-Hydroxytryptamine Receptor 2B)HTR2C (5-hydroxytryptamine 2C receptor)AR (Adrenergic receptors)DRD (Dopamine receptors)H (Histamine receptors)SERT (Sodium-dependent serotonin transporter)
Beyond the preview
Go deeper on Pecilocin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pecilocin.